d961
Small moleculeexperimental
Clinical trial activity
6 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Jun 1, 2009 (NCT00930215)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- d961
- d961h
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02153398 | Phase 3 | Jun 1, 2014 | AstraZeneca |
| NCT01964131 | Phase 1 | Oct 1, 2013 | AstraZeneca, Hakata Clinic Medical Co. LTA |
| NCT01595425 | Phase 1 | May 1, 2012 | AstraZeneca, Hakata Clinic Medical Co. LTA |
| NCT01494402 | Phase 1 | Jan 1, 2012 | AstraZeneca |
| NCT01159145 | Phase 1 | Jul 1, 2010 | AstraZeneca |
| NCT00930215 | Phase 1 | Jun 1, 2009 | AstraZeneca, Kyushu Clinical Pharmacolgy Reasearch Clinic |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| AstraZeneca | For profit | 6 | 6 | 2 | 2009 |
| Hakata Clinic Medical Co. LTA | For profit | 2 | 0 | 1 | 2012 |
| Kyushu Clinical Pharmacolgy Reasearch Clinic | Academic/Hospital | 1 | 0 | 1 | 2009 |
3 organizations
Page 1 / 1